Literature DB >> 12691123

Combined right atrial resection for lung cancer that developed intractable atrial flutter.

Mitsunori Ohta1, Kenji Hazama, Koji Kagisaki, Goro Matsumiya, Hiroyuki Nakayama, Hikaru Matsuda.   

Abstract

We have encountered a patient with primary lung cancer with invasion into the right atrial wall with N2 disease. Complete resection of the tumor combined with the right atrial wall was achieved under cardiopulmonary bypass after induction chemoradiotherapy. Pathological results confirmed ypT0N0M0. Postoperatively, atrial flutter resistant to rate control with calcium-antagonists and beta-blockers was treated with catheter ablation of the atrioventricular node.

Entities:  

Mesh：

Year:  2003        PMID： 12691123     DOI： 10.1007/s11748-003-0085-5

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN： 1344-4964


  6 in total

1.  Results of surgical treatment of stage III lung cancer invading the mediastinum.

Authors:  M E Burt; A H Pomerantz; M S Bains; P M McCormack; L R Kaiser; B S Hilaris; N Martini
Journal:  Surg Clin North Am       Date:  1987-10       Impact factor: 2.741

2.  Ventricular tachycardia as a complication of atrial flutter ablation.

Authors:  H Ramanna; R Derksen; A Elvan; T A Simmers; F H Wittkampf; R N Hauer; E Robles de Medina
Journal:  J Cardiovasc Electrophysiol       Date:  2000-04

3.  Primary cardiac angiosarcoma associated with cardiac tamponade: case report.

Authors:  K Oshima; A Ohtaki; M Kano; S Tange; Y Hasegawa; F Ikeda; S Ishikawa; Y Morishita
Journal:  Jpn Circ J       Date:  1999-10

4.  Operative strategies for resection of pulmonary sarcomas extending into the left atrium.

Authors:  R J Korst; T K Rosengart
Journal:  Ann Thorac Surg       Date:  1999-04       Impact factor: 4.330

5.  Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805.

Authors:  K S Albain; V W Rusch; J J Crowley; T W Rice; A T Turrisi; J K Weick; V A Lonchyna; C A Presant; R J McKenna; D R Gandara
Journal:  J Clin Oncol       Date:  1995-08       Impact factor: 44.544

6.  Induction chemotherapy for T4 centrally located non-small cell lung cancer.

Authors:  E A Rendina; F Venuta; T De Giacomo; A M Ciccone; G Ruvolo; G F Coloni; C Ricci
Journal:  J Thorac Cardiovasc Surg       Date:  1999-02       Impact factor: 5.209
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.